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EDITORIAL 
Thyroid: From Genes to the Disease 
  This issue of Current genomics is devoted to a broad spectrum of thyroid disorders which occur in the population with a 
high frequency and represent an important clinical problem to thyroid specialists all over the world. Understanding the disease
pathophysiology represents an important tool for clinicians confronting various diagnostic and therapeutic challenges in 
managing patients. In the last decade we have been facing a tremendous advance in our knowledge and numerous evidence of a 
susceptibility to various thyroid disorders. All this is helping us to understand the mechanisms, offering promises for prevention 
and even having an impact on the way we treat patients. It is now clear that a certain genotype in combination with a proper 
environmental trigger is crucial for the disease development, but several steps from this point to the clinical disease remain to 
be elucidated. This special focus issue summarizes current knowledge of thyroid genetics, emphasizing the importance of 
genetic contribution to a distinctive clinical outcome in thyroid autoimmune disease and in thyroid neoplasm.  
  In thyroid autoimmune disease, the evidence on genetic susceptibility obtained by epidemiological, family and twin studies 
has been confirmed using the whole genome and candidate gene approaches. Those studies helped to uncover major candidate 
genes, some of them being thyroid specific, while others are being involved in the immune regulation. Brand and Gough 
comprehensively reviewed immunogenetic mechanisms of thyroid autoimmunity and genotyping technologies, illustrating both 
historical and recent aspects as well as future challenges. In spite of shared genetic predisposal factors, different immunogenetic 
pathways lead to specific subtypes of thyroid autoimmunity, such as Graves’ disease, Graves’ ophthalmopathy and 
Hashimoto’s thyroiditis. Detailed up-date on the current knowledge of genetic markers associated with Graves’ disease, 
presented by Ploski and colleagues, also explains a functional significance of observed associations and genotype-phenotype 
correlations. Immunogenetics of Graves’ ophthalmopathy, being clinically detected in up to 50% of patients with Graves’ 
disease, is reviewed by Khalilzadeh and colleagues, emphasizing both genetic background and putative events in immune 
activation in the orbit. In contrast to Graves’ disease, where humoral immune response predominates, cell-mediated immune 
response is characteristic for Hashimoto’s thyroiditis. Zaletel and Gaber  ek provided an extensive overview of the possible 
triggers as well as putative mechanisms leading to the clinical disease.  
  When discussing thyroid tumors, thyroid nodule is a frequent finding in adults, especially in those undergoing thyroid 
ultrasound examinations. Taking into account a high prevalence and most frequently a benign nature, diagnosing of thyroid 
carcinoma seems like looking for a needle in a haystack. Although fine needle aspiration biopsy is a convenient and the best 
non-surgical diagnostic tool for distinguishing between benign and malignant thyroid lesion, its accuracy varies with the 
histological subtype of thyroid nodule and in a high percentage of specimen indeterminate cytology is reported. The article of 
Cerutti is a detailed review of all different approaches used in recent years to overcome a problem of differentiation of benign
from malignant thyroid tumors, emphasizing molecular markers that may improve diagnostic accuracy and help to avoid 
unnecessary treatment of benign tumors. Detection of specific genetic alterations in thyroid cancer seems to be useful not only
for the diagnosis, but also for the prognosis of the disease. While the author Gomez Saez described different genetic 
abnormalities focusing on differentiated histological subtypes of thyroid carcinoma, Soares and co-workers reviewed the most 
relevant genetic alterations in aggressive poorly differentiated and undifferentiated thyroid carcinomas. The current knowledge
and approaches in medullary thyroid carcinoma are summarized by Taccaliti and colleagues, focusing on the central role of 
RET proto-oncogene in management of patients and their families. In the recent years, the rapidly growing knowledge of the 
molecular pathways in thyroid cancer enabled the development of new therapeutic agents. Antonelli and co-workers 
contributed a timely review of this relevant topic, providing both an overview on molecular pathways being explored as 
therapeutic targets and detailed information on new targeted therapies for thyroid carcinoma.  
  Hopefully, the selected topics of this thematic issue will offer critically summarized and timely information from the field of
thyroid pathology relevant to physicians, clinical researchers and basic scientists. I would especially like to thank the reviewers 
for their valuable time, comments, and suggestions that contributed to an even better quality of the reviews. Finally, let me 
thank Editor-in-Chief, Dr. Christian Neri, and his co-workers for the trust and support during the process of preparing this 
special focus issue.  
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